Memorial Sloan Kettering Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1884-01-01

Employees: 10K

Market Cap: -

Website: http://www.mskcc.org

Clinical Trials

Improving a Bayesian Model's Survival Estimates in Patients Needing Surgery for Bone Metastases

Active, not recruiting

Conditions: Bone Metastases

Interventions: Other: blood sampling, the SF-36 questionnaire

First Posted Date: 2011-11-11

Last Posted Date: 2024-12-04

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 230

Registration Number: NCT01470105

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
Montefiore Medical Center, Bronx, New York, United States

Understanding Symptom Recognition and Treatment Decision-making in Hispanic/Latino Lung Cancer Patients

Completed

Conditions: Lung Cancer

Interventions: Behavioral: semi-structured interviews

First Posted Date: 2011-11-08

Last Posted Date: 2016-02-11

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 25

Registration Number: NCT01466946

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Lenalidomide Intensification in Patients With Serologic/Asymptomatic Progression of Multiple Myeloma While on Lenalidomide Maintenance

Phase 2

Completed

Conditions: Multiple Myeloma

Interventions: Drug: lenalidomide

First Posted Date: 2011-11-02

Last Posted Date: 2022-05-06

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 11

Registration Number: NCT01463670

Locations: 🇺🇸
North Shore LIJ, New Hyde Park, New York, United States
🇺🇸
Memoral Sloan Kettering Cancer Center, Basking Ridge, New Jersey, United States
🇺🇸
Stamford Hospital, Stamford, Connecticut, United States

and more 8 locations

Feasibility and Psychometric Properties of Paper vs. Web vs. Automated Telephone Administration of Patient Reported Outcome Surveys

Completed

Conditions: Colon Cancer
Rectal Cancer

Interventions: Behavioral: Surveys

First Posted Date: 2011-10-25

Last Posted Date: 2021-09-10

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 325

Registration Number: NCT01458509

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Immune Responses to Autologous Langerhans-type Dendritic Cells Electroporated With mRNA Encoding a Tumor-associated Antigen in Patients With Malignancy: A Single-arm Phase I Trial in Melanoma

Phase 1

Completed

Conditions: Melanoma

Interventions: Biological: Langerhans-type dendritic cells (a.k.a. Langerhans cells or LCs)

First Posted Date: 2011-10-20

Last Posted Date: 2023-01-13

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 9

Registration Number: NCT01456104

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

BEZ235 in Patients With Advanced Renal Cell Carcinoma (RCC)

Phase 1

Terminated

Conditions: Renal Cancer

Interventions: Drug: BEZ235

First Posted Date: 2011-10-18

Last Posted Date: 2016-02-29

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 10

Registration Number: NCT01453595

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Acute Changes in Endothelial Function in Germ Cell Tumor Patients Treated With Cisplatin and Untreated Germ Cell Tumor Controls

Active, not recruiting

Conditions: Germ Cell Cancer

Interventions: Other: Endo-PAT2000 testing

First Posted Date: 2011-10-18

Last Posted Date: 2024-11-08

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 44

Registration Number: NCT01453660

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Neoadjuvant Platinum-based Chemotherapy for Patients With Resectable , Non-small Cell Lung Cancer With Switch to Chemotherapy Alternative in Nonresponders (NEOSCAN)

Phase 2

Completed

Conditions: Lung Cancer

Interventions: Drug: pemetrexed
Drug: cisplatin
Drug: Carboplatin
Drug: Gemcitabine Hydrochloride
Drug: Vinorelbine Tartrate
Drug: Docetaxel

First Posted Date: 2011-09-29

Last Posted Date: 2018-08-09

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 42

Registration Number: NCT01443078

Locations: 🇺🇸
Memorial Sloan-Kettering at Mercy Medical Center, Rockville Centre, New York, United States
🇺🇸
Memorial Sloan-Kettering Cancer Center at Phelps Memorial Hospital Center, Sleepy Hollow, New York, United States
🇺🇸
Memoral Sloan Kettering Cancer Center, Basking Ridge, New Jersey, United States

and more 2 locations

Acute Normovolemic Hemodilution in Patients Undergoing Cytoreductive Surgery for Advanced Ovarian Cancer

Not Applicable

Completed

Conditions: Primary Peritoneal Carcinoma
Epithelial Ovarian Cancer
Fallopian Tube Cancer

Interventions: Procedure: Acute Normovolemic Hemodilution

First Posted Date: 2011-09-28

Last Posted Date: 2019-07-05

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 52

Registration Number: NCT01442051

Locations: 🇺🇸
Memoral Sloan Kettering Cancer Center, Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
Memorial Sloan Kettering West Harrison, Harrison, New York, United States

and more 1 locations

Ofatumumab With or Without Bendamustine for Patients With Mantle Cell Lymphoma Ineligible for Autologous Stem Cell Transplant

Phase 2

Completed

Conditions: Mantle Cell Lymphoma

Interventions: Biological: Ofatumumab (This arm is closed)
Other: Ofatumumab + Bendamustine

First Posted Date: 2011-09-21

Last Posted Date: 2023-09-13

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 30

Registration Number: NCT01437709

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center at Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering West Harrison, Harrison, New York, United States
🇺🇸
Memorial Sloan Kettering Cancer Center @ Suffolk, Commack, New York, United States

and more 3 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy